The long-term postpartum anxiety and depression outcomes for mothers with COVID-19 during pregnancy

The COVID-19 pandemic is associated with negative mental outcomes in the early postpartum period. Objective: To assess the long-term postpartum mental health of women infected with COVID-19 during pregnancy. Methods: Cross-sectional study in 101 pregnant women who gave birth in a tertiary center during the COVID-19 pandemic, between March 31, 2020, and November 30, 2021. The pregnant women were classified into 2 groups as COVID-19 positive (study group, n=52) and COVID-19 negative (control group, n=49). Sociodemographic and obstetric data were collected by questionnaire in the early (≤6 months) and late (6-18 months) postpartum periods. Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI) scores were calculated by analysis of the participants' data. Results: The mean BDI score and the rate of depression (BDI score >13) in COVID-19 positive patients were higher in the early postpartum period than in the late postpartum period. According to multivariate linear regression analysis, there was a significant correlation between the BDI score of COVID-19 patients and educational level and employment status. According to the same analysis, there was a significant correlation between the BAI score of COVID-19 patients and spousal support, marital relationship, and birth-related diseases. We found that COVID-19 positive and COVID-19 negative patients had similar BDI and BAI scores in the early (≤6 months) and late (6-18 months) postpartum periods. In addition, rates of anxiety and depression were similar in both groups at the same postpartum periods. Conclusion: In our study, COVID-19 infection in pregnancy had no significant additional impact on long-term postpartum maternal mental health.

Coronavirus Disease-Induced Acute Myocarditis: Two Clinical Presentations with Different Electrocardiographic Findings

Background: In this report, we present two cases of coronavirus disease (COVID-19)-related acute myocarditis (AM) with different clinical presentations and electrocardiographic (ECG) findings. Case Report: The first case was a 33-year-old male patient who presented with chest pain to the emergency department (ED). The ECG result suggested an acute coronary syndrome (ACS). However, coronary angiography (CAG) results showed normal coronary arteries, and the cardiac magnetic resonance imaging findings were compatible with COVID-19-induced AM. The ECG revealed a normalization of the T-wave negativity in the anterolateral precordial leads. The second case was a 41-year-old female patient who presented with ST-elevation myocardial infarction (STEMI) to the ED. CAG revealed normal coronary arteries, and the reverse-transcription polymerase chain reaction test result for COVID-19 was positive. The patient was diagnosed as having COVID-19-induced AM. Conclusion: Our cases demonstrate that clinicians should be aware that some patients with COVID-19-induced AM can present with ECG findings mimicking ACS, including STEMI.

Prognostic significance of N-Terminal Pro-BNP in patients with COVID-19 pneumonia without previous history of heart failure

Introduction: The objective of the present research was to evaluate the possible association between the N-terminal pro-brain type natriuretic peptide (NT-proBNP) levels and in-hospital mortality in coronavirus disease 2019 (COVID-19) pneumonia patients who did not have pre-existing heart failure (HF). Methods: A total of 137 consecutive patients without pre-existing HF and hospitalized due to COVID-19 pneumonia were enrolled into the current research. The main outcome of the research was the in-hospital death. The independent parameters linked with the in-hospital death were determined by multivariable analysis. Results: A total of 26 deaths with an in-hospital mortality rate of 18.9% was noted. Those who died were older with an increased frequency of comorbidities such as hypertension, chronic kidney disease, coronary artery disease, stroke and dementia. They had also increased white blood cell (WBC) counts and had elevated glucose, creatinine, troponin I, and NTpro- BNP levels but had decreased levels of hemoglobin. By multivariable analysis;age, NT-pro-BNP, WBC, troponin I, and creatinine levels were independently linked with the in-hospital mortality. After ROC evaluation, the ideal value of the NT-pro-BNP to predict the in-hospital mortality was found as 260 ng/L reflecting a sensitivity of 82% and a specificity of 93% (AUC:0.86;95% CI: 0.76-0.97). Conclusion: The current research clearly shows that the NT-proBNP levels are independently linked with the in-hospital mortality rates in subjects with COVID-19 pneumonia and without HF. Thus, we believe that this biomarker can be used as a valuable prognostic parameter in such cases.

Comparison of D-dimer level measured on the third day of hospitalization with D-dimer level in predicting in-hospital mortality in COVID-19 patients

Objective: The present study aimed to compare the value of D-dimer measured on the 3rd day of hospitalization with admission D-dimer level in predicting in-hospital mortality in coronavirus disease 2019 (COVID-19) cases. Method: In total, 231 patients with COVID-19 disease were included in the study. D-dimer levels were estimated using immunoturbidimetric assay with normal range of 0-500 μg/mL. In the current research, the primary outcome was the in-hospital mortality. Results: In the present research, 39 (16.8%) COVID-19 cases died during the index hospitalization. In a multivariable analysis;age, D-dimer (3rd day) (OR: 1.00, 95% CI: 1.00-1.00, p<0.001), WBC count, and creatinine were independent predictors of the in-hospital death for COVID-19 cases. The ideal value of D-dimer level on the 3rd day of hospitalization was 774 μq/mL (area under curve (AUC): 0.903, 95% CI: 0.836-0.968;p<0.01) with sensitivity of 83.2% and specificity of 83.6%. It was noted that D-dimer level on the 3rd day of hospitalization had a higher sensitivity (83.2% vs 67.6%, respectively) and AUC value than that of D-dimer level on admission (0.903 vs 0.799, respectively). Conclusion: The main finding in this investigation was that D-dimer elevation on the 3rd of hospitalization is more sensitive predictor of in-hospital mortality than D-dimer elevation on admission in COVID-19 patients. Even though further investigations are needed to forecast precise prognosis in patients with COVID-19 disease in terms of D-dimer levels, we believe that D-dimer levels on the 3rd day of hospitalization have an enhanced potential to be used as a prognostic marker in routine clinical practice. (Figure Presented).